ReviewJournal of women's health (2002)2021
Sleep-Disordered Breathing and Pregnancy-Related Cardiovascular Disease.
Review in Journal of women's health (2002), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 20 citations in OpenAlex.
- The implications of maternal sleep disruption on cardiovascular adaptations and cardiometabolic outcomes.The Lancet. Obstetrics, gynaecology, & women's health · 2026Article
- Prevalence and associated factors of individuals at risk for obstructive sleep apnea in urban, stock-raising, and agricultural Xinjiang, Northwest China, a cross-sectional study.BMC public health · 2026Article
- Prenatal maternal sleep and maternal-infant attachment: a systematic review.Frontiers in sleep · 2025Review
- Daily changes in sleep stages and associated cardiovascular parameters during pregnancy: using a wearable device.Frontiers in global women's health · 2025Article
- Clinical features and outcomes of pregnancies complicated by coexisting gestational diabetes and hypertensive disorders.Frontiers in medicine · 2025Article
- Lifestyle and the hypertensive disorders of pregnancy in nulliparous women in the United States: a secondary data analysis of the nuMom2b.BMC pregnancy and childbirth · 2023Article
- Poor sleep quality and associated factors among HIV-positive pregnant women in Northwest, Ethiopia: a facility-based, cross-sectional study.BMC psychiatry · 2022Article
- Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention.Current atherosclerosis reports · 2022Review
- Sleep patterns modify the association of 25(OH)D with poor cardiovascular health in pregnant women.Frontiers in nutrition · 2022Article
- Sleep quality and associated factors among pregnant women attending antenatal care at Jimma Medical Center, Jimma, Southwest Ethiopia, 2020: cross-sectional study.BMC psychiatry · 2021Article
- The intersection of women's health, lung health, and disease.American journal of physiology. Lung cellular and molecular physiology · 2021Article
- Summary and Conclusion: Framing a New Research Agenda on Maternal Morbidities and Mortality in the United States.Journal of women's health (2002) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sleep-disordered breathing (SDB) is a serious medical condition characterized by intermittent episodes of airflow limitation, intermittent hypoxia, and sleep disturbance triggering a pattern of autonomic dysfunction associated with hypertension, diabetes, and other adverse health conditions. SDB incidence is two to three times higher during pregnancy and is associated with an increased risk of cardiometabolic complications, including pre-eclampsia and gestational diabetes. Treatments to protect breathing during sleep are available, pointing to SDB as a potential therapeutic target to reduce maternal cardiometabolic morbidity. However, in clinical practice, the majority of SDB cases in pregnancy are undiagnosed, indicating a need to improve screening for SDB risk factors and referral for diagnostic testing. Furthermore, definitive clinical trials are needed to determine the extent to which SDB intervention reduces the risk of adverse cardiovascular and neonatal outcomes in pregnancy. This review article discusses an accumulation of research pointing to SDB as a prevalent risk factor for gestational cardiometabolic disease, as well as a potential therapeutic target to reduce cardiometabolic morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.